BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 37685358)

  • 1. An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide.
    Bevere M; Masetto F; Carazzolo ME; Bettega A; Gkountakos A; Scarpa A; Simbolo M
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review).
    Ciobanu OA; Martin S; Fica S
    Exp Ther Med; 2021 Dec; 22(6):1479. PubMed ID: 34765020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.
    Mariën L; Islam O; Chhajlani S; Lybaert W; Peeters M; Van Camp G; Op de Beeck K; Vandamme T
    Curr Treat Options Oncol; 2023 Dec; 24(12):1833-1851. PubMed ID: 37989978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors.
    Malczewska A; Kos-Kudła B; Kidd M; Drozdov I; Bodei L; Matar S; Oberg K; Modlin IM
    Adv Med Sci; 2020 Mar; 65(1):18-29. PubMed ID: 31841822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.
    Modlin IM; Bodei L; Kidd M
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
    Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
    Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.
    Oberg K; Krenning E; Sundin A; Bodei L; Kidd M; Tesselaar M; Ambrosini V; Baum RP; Kulke M; Pavel M; Cwikla J; Drozdov I; Falconi M; Fazio N; Frilling A; Jensen R; Koopmans K; Korse T; Kwekkeboom D; Maecke H; Paganelli G; Salazar R; Severi S; Strosberg J; Prasad V; Scarpa A; Grossman A; Walenkamp A; Cives M; Virgolini I; Kjaer A; Modlin IM
    Endocr Connect; 2016 Sep; 5(5):174-87. PubMed ID: 27582247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy.
    Filosso PL; Öberg K; Malczewska A; Lewczuk A; Roffinella M; Aslanian H; Bodei L
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1195-1202. PubMed ID: 32047924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NETest: The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors.
    Modlin IM; Kidd M; Malczewska A; Drozdov I; Bodei L; Matar S; Chung KM
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):485-504. PubMed ID: 30098712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.
    Liu E; Paulson S; Gulati A; Freudman J; Grosh W; Kafer S; Wickremesinghe PC; Salem RR; Bodei L
    Oncologist; 2019 Jun; 24(6):783-790. PubMed ID: 30158287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood mRNA Measurement (NETest) for Neuroendocrine Tumor Diagnosis of Image-Negative Liver Metastatic Disease.
    Malczewska A; Bodei L; Kidd M; Modlin IM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):867-872. PubMed ID: 30358858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in gastroenteropancreatic neuroendocrine neoplasms.
    Jacoba IM; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2023 Jun; 30(3):175-180. PubMed ID: 36895178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.
    Fernandez CJ; Agarwal M; Pottakkat B; Haroon NN; George AS; Pappachan JM
    World J Gastrointest Surg; 2021 Mar; 13(3):231-255. PubMed ID: 33796213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future.
    Komarnicki P; Musiałkiewicz J; Stańska A; Maciejewski A; Gut P; Mastorakos G; Ruchała M
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy.
    Ćwikła JB; Bodei L; Kolasinska-Ćwikła A; Sankowski A; Modlin IM; Kidd M
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1437-45. PubMed ID: 26348352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NETest: A Systematic Review Focusing on the Prognostic and Predictive Role.
    Puliani G; Di Vito V; Feola T; Sesti F; Centello R; Pandozzi C; Tarsitano MG; Verrico M; Lenzi A; Isidori AM; Giannetta E; Faggiano A
    Neuroendocrinology; 2022; 112(6):523-536. PubMed ID: 34515175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility.
    Modlin IM; Kidd M; Falconi M; Filosso PL; Frilling A; Malczewska A; Toumpanakis C; Valk G; Pacak K; Bodei L; Öberg KE
    Ann Oncol; 2021 Nov; 32(11):1425-1433. PubMed ID: 34390828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
    Koffas A; Giakoustidis A; Papaefthymiou A; Bangeas P; Giakoustidis D; Papadopoulos VN; Toumpanakis C
    Front Surg; 2023; 10():1064145. PubMed ID: 36950054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumors.
    Genç CG; Jilesen APJ; Nieveen van Dijkum EJM; Klümpen HJ; van Eijck CHJ; Drozdov I; Malczewska A; Kidd M; Modlin I
    J Surg Oncol; 2018 Jul; 118(1):37-48. PubMed ID: 30114319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
    Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
    Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.